Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDR | P35968 | 13/20 | 0.64 |
| ▸ | ABCG2 | Q9UNQ0 | 3/20 | 0.61 |
| ▸ | EGFR | P00533 | 9/20 | 0.61 |
| ▸ | MAPK14 | Q16539 | 2/20 | 0.61 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.61 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.61 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.61 |
| ▸ | AURKA | O14965 | 1/20 | 0.59 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.59 |
| ▸ | ABCB1 | P08183 | 2/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6165277 | 1.00 | KDR (0.64) | KDRABCG2EGFRMAPK14HDAC3 | |
| SCHEMBL6163282 | 0.93 | ABCG2 (0.64) | KDRABCG2EGFRHDAC3HDAC1 | |
| SCHEMBL6165229 | 0.93 | ABCG2 (0.64) | KDRABCG2EGFRHDAC3HDAC1 | |
| SCHEMBL6167032 | 0.92 | HDAC3 (0.57) | KDRABCG2EGFRMAPK14HDAC3 | |
| SCHEMBL6163054 | 0.92 | HDAC3 (0.57) | KDRABCG2EGFRMAPK14HDAC3 | |
| SCHEMBL6162947 | 0.89 | KDR (0.74) | KDRABCG2EGFRHDAC3HDAC1 | |
| SCHEMBL6162938 | 0.89 | KDR (0.74) | KDRABCG2EGFRHDAC3HDAC1 | |
| SCHEMBL6163496 | 0.87 | KDR (0.70) | KDRABCG2EGFRHDAC3HDAC1 | |
| SCHEMBL6166357 | 0.87 | KDR (0.70) | KDRABCG2EGFRHDAC3HDAC1 | |
| SCHEMBL6163276 | 0.86 | HDAC1 (0.72) | KDREGFRHDAC3HDAC1HDAC6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1218357-B1 | QUINAZOLINE DERIVATIVES | ASTRAZENECA AB (SE) | 2005-04-06 | — | — | EP | claimed |